Hanson Wade

R&D

Partner Content

Antifibrotic Drug Development Summit

As fibrosis stakeholders invest in bolstering their early pipeline to limit early candidate drop off, the 7th Antifibrotic Drug Development (AFDD) Summit explores actionable strategies to t

R&D

Partner Content

Champion Innovation at the 7th Dermatology Drug Development ...

Following 6 FDA approvals of JAK inhibitors and the breakthroughs of the first approved therapies in Prurigo Nodularis, Alopecia Areata and a gene therapy for Dystrophic Epidermolysis Bullo

R&D

Partner Content

2nd LNP Immunogenicity & Toxicity Summit

Back for its second iteration, the LNP Immunogenicity & Toxicity Summit (December 11-13, 2023 | Boston) will bring together 1

R&D

Partner Content

5th Annual Gene Therapy Analytical Development Summit 2023

Behind regulatory milestones like the recent accelerated FDA approval for Duchenne Muscular Dystrophy, robust and detailed analytics are the cornerstone of gene therapy development.

R&D